Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial
The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
Unlabelled Vitamin K2 may preserve bone strength and reduce fracture risk. In this randomised double-blind placebo-controlled trial among healthy postmenopausal Norwegian women, 1 year supplementation of vitamin K2 in the form of Natto capsules had no effect on bone loss rates. Introduction Japanese studies indicate that vitamin K2 (menaquinone-7 (MK-7)) intake may preserve bone strength, but this has not been documented in Europeans. The aim of this study was to assess the effect of MK-7 on bone mineral density (BMD) changes in postmenopausal Norwegian women. Methods Three hundred thirty-four healthy women between 50 and 60 years, 1-5 years after menopause, were recruited to a randomised double-blind placebo-controlled trial. The participants were randomly assigned into two groups, one receiving 360 microg MK-7 in the form of Natto capsules and the other the same amount of identical-looking placebo capsules containing olive oil. BMD was measured at total hip, femoral neck, lumbar spine and total body at baseline and 12 months together with serum levels of bone-specific alkaline phosphatase, Crosslaps, total osteocalcin (N-mid OC), carboxylated (cOC) and under-carboxylated osteocalcin (ucOC). Results After 12 months, there were no statistical differences in bone loss rates between the groups at the total hip or any other measurement site. Serum levels of cOC increased and ucOC decreased in the treatment versus the placebo group (p Conclusion MK-7 taken as Natto over 1 year re…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In another eight RCTs (not shown in table 3), the authors cited affected trial reports to draw attention to the disparities between their own findings and those reported.66–73”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [71]
Citations
Cites
4 retracted
Ishida, Y., & Kawai, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.019 · Cited by 132
RetractedSato, Y., Honda, Y., Kuno, H., & Oizumi, K. (1998) · Bone · doi:10.1016/s8756-3282(98)00108-2 · Cited by 77
RetractedSato, Y., Honda, Y., Kaji, M., Asoh, T., Hosokawa, K., Kondo, I., & Satoh, K. (2002) · Bone · doi:10.1016/s8756-3282(02)00783-4 · Cited by 76
RetractedSato, Y., Kanoko, T., Satoh, K., & Iwamoto, J. (2005) · Bone · doi:10.1016/j.bone.2004.09.018 · Cited by 59
RetractedAn estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704 · cited 2×
“Fracture risk is multifactorial and complex [2], but the diagnosis of osteoporosis is based on an assessment of skeletal mass per unit area, defined as bone mineral density (BMD) [ 3 ].”
BackgroundMethodFracture Prevention With Vitamin D Supplementation: A Meta-analysis of Randomized Controlled Trials
Bischoff-Ferrari, H. A., Willett, W. C., Wong, J. B., Giovannucci, E., Dietrich, T., & Dawson-Hughes, B. (2005) · JAMA · doi:10.1001/jama.293.18.2257 · Cited by 1,530 · cited 1×
“Although recent meta-analyses have questioned the role of calcium [37] and vitamin D [ 38 ] intake for fracture prevention in younger adults, the lack of calcium and vitamin D supplementation in each arm is a limitation [39] of the study.”
ResultPredictive Value of BMD for Hip and Other Fractures
Johnell, O., Kanis, J. A., Oden, A., Johansson, H., De Laet, C., Delmas, P., Eisman, J. A., Fujiwara, S., Kroger, H., Mellstrom, D., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050304 · Cited by 1,445
Kanis, J. A., Borgstrom, F., De Laet, C., Johansson, H., Johnell, O., Jonsson, B., Oden, A., Zethraeus, N., Pfleger, B., & Khaltaev, N. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1780-5 · Cited by 1,233 · cited 1×
“Fracture risk is multifactorial and complex [ 2 ], but the diagnosis of osteoporosis is based on an assessment of skeletal mass per unit area, defined as bone mineral density (BMD) [3].”
BackgroundOsteocytes, mechanosensing and Wnt signaling
Bonewald, L. F., & Johnson, M. L. (2008) · Bone · doi:10.1016/j.bone.2007.12.224 · Cited by 1,076
An Update on the Diagnosis and Assessment of Osteoporosis with Densitometry
Kanis, J. A., & Glüer, C.-C. (2000) · Osteoporosis International · doi:10.1007/s001980050281 · Cited by 952
Bone strength and its determinants
Ammann, P., & Rizzoli, R. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1345-4 · Cited by 761 · cited 1×
“However, fracture risk in the age group between 50 and 60 years is still low [35], and BMD is a good surrogate measure of bone strength, predicting 60–70% of its variation [ 36 ].”
BackgroundLaw, M. R., & Hackshaw, A. K. (1997) · BMJ · doi:10.1136/bmj.315.7112.841 · Cited by 666
International Variations in Hip Fracture Probabilities: Implications for Risk Assessment
Kanis, J. A., Johnell, O., De Laet, C., Jonsson, B., Oden, A., & Ogelsby, A. K. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1237 · Cited by 605
Vitamin K intake and hip fractures in women: a prospective study
Feskanich, D., Weber, P., Willett, W. C., Rockett, H., Booth, S. L., & Colditz, G. A. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.74 · Cited by 484
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc, P., Chapuy, M. C., Meunier, P. J., & Delmas, P. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116387 · Cited by 484 · cited 1×
“ucOC is furthermore inversely correlated with hip BMD [15] and regarded as a marker of hip fracture risk in elderly women [13, 16 ].”
BackgroundShiraki, M., Shiraki, Y., Aoki, C., & Miura, M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.515 · Cited by 408
Vergnaud, P., Garnero, P., Meunier, P. J., Bréart, G., Kamihagi, K., & Delmas, P. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3805 · Cited by 389 · cited 2×
“ucOC is furthermore inversely correlated with hip BMD [15] and regarded as a marker of hip fracture risk in elderly women [ 13 , 16].”
BackgroundCockayne, S., Adamson, J., Lanham-New, S., Shearer, M. J., Gilbody, S., & Torgerson, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1256 · Cited by 361 · cited 3×
“The bone loss rates and lack of observable differences in loss rates between the groups are similar to the results from our study and stand in contrast to the systematic review from 2006 [ 17 ].”
BackgroundResultInfluentialBischoff-Ferrari, H. A., Dawson-Hughes, B., Baron, J. A., Burckhardt, P., Li, R., Spiegelman, D., Specker, B., Orav, J. E., Wong, J. B., Staehelin, H. B., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1780 · Cited by 326 · cited 1×
“Although recent meta-analyses have questioned the role of calcium [ 37 ] and vitamin D [38] intake for fracture prevention in younger adults, the lack of calcium and vitamin D supplementation in each arm is a limitation [39] of the study.”
ResultDeterminants of self-perceived health.
Shields, M., & Shooshtari, S. (2001) · PubMed · Cited by 301
Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
Szulc, P., Arlot, M., Chapuy, M.-C., Duboeuf, F., Meunier, P. J., & Dr. Delmas, P. D. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091012 · Cited by 269 · cited 1×
“ucOC is furthermore inversely correlated with hip BMD [ 15 ] and regarded as a marker of hip fracture risk in elderly women [13, 16].”
BackgroundKaneki, M., Hedges, S. J., Hosoi, T., Fujiwara, S., Lyons, A., Crean, S. J., Ishida, N., Nakagawa, M., Takechi, M., Sano, Y., et al. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00554-2 · Cited by 248
Gundberg, C. M., Nieman, S. D., Abrams, S., & Rosen, H. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5126 · Cited by 239 · cited 1×
“Vitamin K deficiency will cause production of under-carboxylated osteocalcin (ucOC) [13], and ucOC levels are therefore considered to be a sensitive measure of vitamin K status [ 14 ].”
BackgroundVitamin K1 Supplementation Retards Bone Loss in Postmenopausal Women Between 50 and 60 Years of Age
Braam, L. A. J. L. M., Knapen, M. H. J., Geusens, P., Brouns, F., Hamuly�k, K., Gerichhausen, M. J. W., & Vermeer, C. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2084-4 · Cited by 239
Vitamin K intake and bone mineral density in women and men
Booth, S. L., Broe, K. E., Gagnon, D. R., Tucker, K. L., Hannan, M. T., McLean, R. R., Dawson-Hughes, B., Wilson, P. W., Cupples, L. A., & Kiel, D. P. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.512 · Cited by 237 · cited 1×
“Low intake of vitamin K is associated with low BMD [ 9 ] and increased risk of fracture [10].”
BackgroundKnapen, M. H. J., Schurgers, L. J., & Vermeer, C. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0337-9 · Cited by 232 · cited 1×
“In a 3-year study on Dutch postmenopausal women [ 55 ], the authors reported maintenance of calculated bone strength indices.”
BackgroundTen-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
Kanis, J. A., Johnell, O., Oden, A., De Laet, C., Jonsson, B., & Dawson, A. (2002) · Bone · doi:10.1016/s8756-3282(01)00653-6 · Cited by 209 · cited 1×
“However, fracture risk in the age group between 50 and 60 years is still low [ 35 ], and BMD is a good surrogate measure of bone strength, predicting 60–70% of its variation [36].”
BackgroundBolton-Smith, C., McMurdo, M. E., Paterson, C. R., Mole, P. A., Harvey, J. M., Fenton, S. T., Prynne, C. J., Mishra, G. D., & Shearer, M. J. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070116 · Cited by 196 · cited 1×
“Serum levels of ucOC decreased and cOC increased significantly in the treatment group, indicating that the participants took the medication, and that the medication was absorbed and active, but as in other recent trials [18, 19, 43 ], BMD was not maintained despite improvement of OC carboxylation.”
ResultEffect of Vitamin K Supplementation on Bone Loss in Elderly Men and Women
Booth, S. L., Dallal, G., Shea, M. K., Gundberg, C., Peterson, J. W., & Dawson-Hughes, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2490 · Cited by 177 · cited 5×
“Serum levels of ucOC decreased and cOC increased significantly in the treatment group, indicating that the participants took the medication, and that the medication was absorbed and active, but as in other recent trials [ 18 , 19, 43], BMD was not maintained despite improvement of OC carboxylation.”
BackgroundResultInfluentialBinkley, N., Harke, J., Krueger, D., Engelke, J., Vallarta-Ast, N., Gemar, D., Checovich, M., Chappell, R., & Suttie, J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081254 · Cited by 163 · cited 3×
“In a 3-year study, daily supplementation of phylloquinone significantly decreased serum ucOC in elderly US women and men without any effect on lumbar or totalbody BMD compared to the placebo group [18], and in a recently published study, 12 months treatment with phylloquinone or MK-4 also reduced serum ucOC without an…”
BackgroundResultInfluentialThe structural and biomechanical basis of the gain and loss of bone strength in women and men
Seeman, E. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00078-6 · Cited by 163 · cited 2×
“This loss of bone mass leads to decreased structural strength and increased risk of fracture [ 8 ].”
BackgroundChapurlat, R. D., Garnero, P., Sornay‐Rendu, E., ARLOT, M. E., Claustrat, B., & Delmas, P. D. (2000) · Osteoporosis International · doi:10.1007/s001980070091 · Cited by 140 · cited 2×
“We calculated that a mean annual loss of 1.1% with a standard deviation of 0.9% [28] would be a conservative estimate for the annual loss in this age group [5, 6]. A mean loss of 0.38% at the total hip in all participants was less than expected [ 5 , 6, 30, 31].”
BackgroundMethodInfluentialLanham-New, S. A. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108007003 · Cited by 140 · cited 1×
“Although recent meta-analyses have questioned the role of calcium [37] and vitamin D [38] intake for fracture prevention in younger adults, the lack of calcium and vitamin D supplementation in each arm is a limitation [ 39 ] of the study.”
ResultMinerals and vitamins in bone health: the potential value of dietary enhancement
Bonjour, J.-P., Guéguen, L., Palacios, C., Shearer, M. J., & Weaver, C. M. (2009) · British Journal of Nutrition · doi:10.1017/s0007114509311721 · Cited by 136 · cited 1×
“With Natto’s possible but still undocumented effect on bone [ 24 ], the aim of this 12-month double-blind placebocontrolled randomised trial was to assess if dietary supplementation of MK-7 taken in the form of Natto capsules would influence bone loss and bone formation markers in early menopausal Norwegian women, wit…”
BackgroundBischoff-Ferrari, H. A., Dawson-Hughes, B. F., Baron, J. A., Burckhardt, P., Li, R., Spiegelman, D. L., SPECKER, B. L., Orav, E. J., Wong, J. B., Staehelin, H. B., et al. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.6.1780 · Cited by 134
Tsugawa, N., Shiraki, M., Suhara, Y., Kamao, M., Tanaka, K., & Okano, T. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.380 · Cited by 127
A Prospective Study of Bone Loss in Menopausal Australian-Born Women
Guthrie, J. R., Ebeling, P. R., Hopper, J. L., Barrett-Connor, E. L., Dennerstein, L., DUDLEY, E. C., Burger, H., & Wark, J. D. (1998) · Osteoporosis International · doi:10.1007/s001980050066 · Cited by 122 · cited 2×
“We calculated that a mean annual loss of 1.1% with a standard deviation of 0.9% [28] would be a conservative estimate for the annual loss in this age group [5, 6]. A mean loss of 0.38% at the total hip in all participants was less than expected [5, 6 , 30, 31].”
BackgroundMethodInfluentialSowers, M. R., Crutchfield, M., Bandekar, R. R., Randolph, J. F., Shapiro, B., Schork, M. A., & Jannausch, M. L. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.7.1134 · Cited by 120
Determinants of Bone Loss from the Femoral Neck in Women of Different Ages
Melton, L. J., Atkinson, E. J., O'Connor, M. K., O'Fallon, W. M., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.24 · Cited by 114
Determinants of Vitamin K Status in Humans
Booth, S. L., & Rajabi, A. A. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(07)00001-5 · Cited by 112 · cited 1×
“Because of differences in side chin length, the effect of MK-7 and MK-4 on bone may not be comparable [12, 53 ].”
BackgroundIwamoto, J., Takeda, T., & Ichimura, S. (2000) · Journal of Orthopaedic Science · doi:10.1007/s007760070003 · Cited by 103 · cited 1×
“Most of the studies indicating a positive effect are on patients with different chronic diseases [45–49], in women with established osteoporosis [40, 50–52], and in studies combining MK-4 and vitamin D3 [ 40 ].”
BackgroundNo effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women
Rejnmark, L., Vestergaard, P., Charles, P., Hermann, A. P., Brot, C., Eiken, P., & Mosekilde, L. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0044-3 · Cited by 103
Inoue, T., Fujita, T., Kishimoto, H., Makino, T., Nakamura, T., Nakamura, T., Sato, T. S., & Yamazaki, K. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0008-8 · Cited by 97 · cited 1×
“However, data from a Japanese trial involving 3,000 patients did not indicate any effect of 36 months daily supplementation of 45 mg MK-4 on vertebral fracture risk [ 58 ].”
BackgroundOrimo, H., Shiraki, M., TOMITA, A., Morii, H., Fujita, T., & Ohata, M. (1998) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050034 · Cited by 94
Longitudinal Changes in Forearm Bone Mineral Density in Women and Men Aged 25–44 Years
Emaus, N., Berntsen, G. K. R., Joakimsen, R. M., & Fønnebø, V. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi258 · Cited by 86 · cited 2×
“We calculated that a mean annual loss of 1.1% with a standard deviation of 0.9% [ 28 ] would be a conservative estimate for the annual loss in this age group [5, 6]. A mean loss of 0.38% at the total hip in all participants was less than expected [5, 6, 30, 31].”
MethodInfluentialSelf-citationSpontaneous postmenopausal bone loss in different skeletal areas—followed up for 15 years
Hansen, M. A., Overgaard, K., & Christiansen, C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100206 · Cited by 85 · cited 1×
“We calculated that a mean annual loss of 1.1% with a standard deviation of 0.9% [28] would be a conservative estimate for the annual loss in this age group [5, 6]. A mean loss of 0.38% at the total hip in all participants was less than expected [5, 6, 30 , 31].”
BackgroundInfluentialRole of K vitamins in the regulation of tissue calcification
Vermeer, C., & Braam, L. A. J. L. M. (2001) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740170021 · Cited by 82 · cited 5×
“Both vitamin K1 (phylloquinone or phytonadione) and K2 (menaquinone) contribute to the vitamin K status in humans [ 12 ] (Table 1). Vitamin K2 is a spectrum of multiple forms where menaquinone-4 (MK-4) and menaquinone-7 (MK-7) are reportedly related to bone mass and fracture risk [11, 12].”
BackgroundInfluentialIwamoto, I., Kosha, S., Noguchi, S., Murakami, M., Fujino, T., Douchi, T., & Nagata, Y. (1999) · Maturitas · doi:10.1016/s0378-5122(98)00114-5 · Cited by 81 · cited 1×
“However, in a 1-year study on Japanese postmenopausal women [ 54 ], BMD decrease was suppressed, but not significantly different from controls.”
BackgroundStimulatory effect of menaquinone-7 (vitamim K2) on osteoblastic bone formation in vitro
Yamaguchi, M., Sugimoto, E., & Hachiya, S. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1017930931736 · Cited by 73
A Generalized Least Significant Change for Individuals Measured on Different DXA Systems
Shepherd, J., & Lü, Y. (2007) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.05.002 · Cited by 72 · cited 1×
“Similarly, the least significant change was calculated for each study centre (2.77×CV %) [ 29 ] at the total hip, and the percentage of participants with significant loss in the two groups was compared using chi-square tests.”
MethodInfluentialYonemura, K., Kimura, M., Miyaji, T., & Hishida, A. (2000) · Calcified Tissue International · doi:10.1007/pl00005832 · Cited by 64
Whelan, A. M., Jurgens, T. M., & Bowles, S. K. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g226 · Cited by 54 · cited 2×
“With increasing age, a larger proportion of women use natural health products also targeted for specific diseases such as osteoporosis [ 61 ].”
BackgroundResultEmaus, N., Berntsen, G. K. R., Joakimsen, R., & Fonnebø, V. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj055 · Cited by 51
Self-citationTime-Dependent Effects of Vitamin K2 (Menatetrenone) on Bone Metabolism in Postmenopausal Women.
OZURU, R., SUGIMOTO, T., YAMAGUCHI, T., & CHIHARA, K. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.363 · Cited by 43 · cited 1×
“In two 48-week Japanese studies on menopausal women taking 45 mg MK-4 daily, ucOC decreased without any effect on lumbar BMD [ 56 ].”
BackgroundKatsuyama, H., Otsuki, T., Tomita, M., Fukunaga, M., Fukunaga, T., Suzuki, N., Saijoh, K., Fushimi, S., & Sunami, S. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.2.231 · Cited by 43
Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver
Shiomi, S. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)03974-6 · Cited by 43
Promotion of Bone Formation by Fermented Soybean (Natto) Intake in Premenopausal Women
KATSUYAMA, H., IDEGUCHI, S., FUKUNAGA, M., FUKUNAGA, T., SAIJOH, K., & SUNAMI, S. (2004) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.50.114 · Cited by 40
1,25-Dihydroxyvitamin D 3 Promotes Vitamin K 2 Metabolism in Human Osteoblasts
Miyake, N., Hoshi, K., Sano, Y., Kikuchi, K., TADANO, K., & Koshihara, Y. (2001) · Osteoporosis International · doi:10.1007/s001980170068 · Cited by 40
KATSUYAMA, H., IDEGUCHI, S., FUKUNAGA, M., SAIJOH, K., & SUNAMI, S. (2002) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.48.207 · Cited by 35
In Vivo and In Vitro Comparison of Densitometers in the NOREPOS Study
Omsland, T. K., Emaus, N., Gjesdal, C. G., Falch, J. A., Tell, G. S., Forsén, L., Berntsen, G., & Meyer, H. E. (2008) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.10.001 · Cited by 35 · cited 1×
“The in vivo coefficient of variation (CV%) for the total hip was 1.14% and 0.82% in Centre 1 and 2, respectively [ 27 ].”
InfluentialSelf-citationVitamin K and the Prevention of Fractures
Tamura, T., Morgan, S. L., & Takimoto, H. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.94-a · Cited by 32 · cited 1×
“These results might have changed the outcome of the systematic review had the data been available for inclusion [ 59 ].”
ResultEffect of vitamin K2treatment on carboxylation of osteocalcin in early postmenopausal women
Yasui, T., Miyatani, Y., Tomita, J., Yamada, M., Uemura, H., Miura, M., & Irahara, M. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600900402 · Cited by 28
Menaquinone-7 regulates gene expression in osteoblastic MC3T3E1 cells
Katsuyama, H., Saijoh, K., Otsuki, T., Tomita, M., Fukunaga, M., & Sunami, S. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.2.279 · Cited by 21
Joly, F., Mayeur, C., Bruneau, A., Lavergne‐Slove, A., Cherbuy, C., Levenez, F., Duée, P., Messing, B., & Thomas, M. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108007957 · Cited by 7
Cited by
The role of menaquinones (vitamin K2) in human health
Beulens, J. W. J., Booth, S. L., van den Heuvel, E. G. H. M., Stoecklin, E., Baka, A., & Vermeer, C. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513001013 · Cited by 318
“Whereas MK-7 at low doses did not affect bone formation((64,65)), intake of natto three times per week increased bone-specific alkaline phosphatase when compared with once-per-week natto intake((95)).”
Walther, B., Karl, J. P., Booth, S. L., & Boyaval, P. (2013) · Advances in Nutrition · doi:10.3945/an.113.003855 · Cited by 271
“Findings from the 2 included studies in which MK-7 supplementation alone was examined were inconsistent with bone health benefits documented at MK-7 doses of 180 mg/d over 1 y in 1 study (75), but not at 360 mg/d over 1 y in another (76).”
BackgroundDietary supplements and disease prevention — a global overview
Rautiainen, S., Manson, J. E., Lichtenstein, A. H., & Sesso, H. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.54 · Cited by 250
Dietary reference values for vitamin K
EFSA Panel on Dietetic Products, N. A. A. (., Turck, D., Bresson, J., Burlingame, B., Dean, T., Fairweather‐Tait, S., Heinonen, M., Hirsch‐Ernst, K. I., Mangelsdorf, I., McArdle, H. J., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4780 · Cited by 218
“…5.2) have been done in Japanese or European adult populations using MK-4 or MK-7 supplementation (Schurgers et al., 2007; Koitaya et al., 2009; Emaus et al., 2010; Bruge et al., 2011; Kanellakis et al., 2012; Nakamura et al., 2014; Inaba et al., 2015), and using MK-7 in children (van Summeren…”
BackgroundMethodInfluentialConcepts and Controversies in Evaluating Vitamin K Status in Population-Based Studies
Shea, M., & Booth, S. (2016) · Nutrients · doi:10.3390/nu8010008 · Cited by 197
Metadata
- Authors
- Emaus, N., Gjesdal, C. G., Almås, B., Christensen, M., Grimsgaard, A. S., Berntsen, G. K. R., Salomonsen, L., & Fønnebø, V.
- Affiliations
- UiT The Arctic University of Norway (NO)
- Haukeland University Hospital (NO)
- University Hospital of North Norway (NO)
- Corresponding author
- Emaus, N.
- Venue
- Osteoporosis International
- Published
- 2009-11-25
- Volume
- 21
- Issue
- 10
- Pages
- 1731-1740
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2026939902
- Cited by
- 102
- References
- 65
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 1 · 2023: 3 · 2022: 8 · 2021: 4 · 2020: 10 · 2019: 7 · 2018: 3 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 5 · 2013: 9 · 2012: 10
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Haukeland Universitetssjukehus
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin K2, menaquinone-7, natto, bone loss, postmenopausal women, bone mineral density, osteocalcin, undercarboxylated osteocalcin, carboxylated osteocalcin, bone-specific alkaline phosphatase, crosslaps, osteoporosis prevention
- MeSH terms
- Double-Blind Method, Female, Femur Neck, Follow-Up Studies, Hip Joint, Humans, Lumbar Vertebrae, Middle Aged, Biomarkers, Bone Density, Osteoporosis, Postmenopausal, Osteocalcin, Dietary Supplements, Vitamin K 2, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.